Skip to main content
placeholder image

Biomarker analysis and final efficacy and safety results of a phase II renal cell carcinoma trial with pazopanib (GW786034), a multi-kinase angiogenesis inhibitor

Journal Article


Abstract


UOW Authors


  •   De Souza, Paul (external author)

Publication Date


  • 2008

Citation


  • Hutson, T. E., Davis, I. D., Machiels, J. H., de Souza, P. L., Baker, K., Bordogna, W., . . . Figlin, R. A. (2008). Biomarker analysis and final efficacy and safety results of a phase II renal cell carcinoma trial with pazopanib (GW786034), a multi-kinase angiogenesis inhibitor. Journal of Clinical Oncology, 26(15_suppl), 5046. doi:10.1200/jco.2008.26.15_suppl.5046

Web Of Science Accession Number


Start Page


  • 5046

End Page


  • 5046

Volume


  • 26

Issue


  • 15_suppl

Place Of Publication


Abstract


UOW Authors


  •   De Souza, Paul (external author)

Publication Date


  • 2008

Citation


  • Hutson, T. E., Davis, I. D., Machiels, J. H., de Souza, P. L., Baker, K., Bordogna, W., . . . Figlin, R. A. (2008). Biomarker analysis and final efficacy and safety results of a phase II renal cell carcinoma trial with pazopanib (GW786034), a multi-kinase angiogenesis inhibitor. Journal of Clinical Oncology, 26(15_suppl), 5046. doi:10.1200/jco.2008.26.15_suppl.5046

Web Of Science Accession Number


Start Page


  • 5046

End Page


  • 5046

Volume


  • 26

Issue


  • 15_suppl

Place Of Publication